Munich - Delayed Quote EUR
Roche Holding AG (RHO5.MU)
278.70
+1.00
+(0.36%)
At close: May 30 at 8:06:37 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
20,094,000
20,094,000
16,095,000
17,803,000
20,976,000
Investing Cash Flow
-11,393,000
-11,393,000
-10,643,000
-2,924,000
-6,552,000
Financing Cash Flow
-6,819,000
-6,819,000
-4,239,000
-16,275,000
-13,108,000
End Cash Position
6,975,000
6,975,000
5,376,000
4,991,000
6,850,000
Capital Expenditure
-5,009,000
-5,009,000
-4,649,000
-4,552,000
-4,549,000
Issuance of Capital Stock
-1,130,000
-1,130,000
-1,144,000
-1,257,000
-1,406,000
Issuance of Debt
7,915,000
7,915,000
8,342,000
8,442,000
20,312,000
Repayment of Debt
-3,387,000
-3,387,000
-1,751,000
-15,433,000
-2,448,000
Repurchase of Capital Stock
--
--
--
0
-18,991,000
Free Cash Flow
15,085,000
15,085,000
11,446,000
13,251,000
16,427,000
12/31/2021 - 6/16/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NOTA.F Novartis AG
97.00
-1.62%
NOT.HM NOVARTIS AG N
100.70
+2.08%
6MK.F Merck & Co., Inc.
67.50
+0.75%
NVSEF Novartis AG
112.00
-0.26%
NOVN.SW Novartis AG
94.03
+1.40%
MDCX Medicus Pharma Ltd.
2.5500
-29.85%
SNY Sanofi
49.37
-5.69%
NVS Novartis AG
115.76
+2.82%
NOVO-B.CO Novo Nordisk A/S
453.65
-2.41%
JNJ Johnson & Johnson
155.21
+1.06%